SpyGlass Versus ESWL for Large Common Bile Duct Stones

Status Completed

Clinical Trial Summary

Overall stone clearance with endoscopic retrograde cholangiopancreatography (ERCP) for choledocholithiasis is a big problem, especially for stones with a diameter greater than 3cm. After ERCP failure, surgery was the option but patients not suitable for surgery were treated through stenting but had to undergo multiple ERCPs and show a success rate of only 44-96%. Recently, choledochoscopic laser, electrohydraulic lithotripsy, SpyGlass, or extracorporeal shock wave lithotripsy (ESWL) have been applied for the treatment of huge bile duct stones. The present study aims to compare the efficacy and safety outcomes of SpyGlass direct vision lithotripsy and ESWL procedures for the removal of large bile duct stones.

Clinical Trial Description

ESWL was first used for the removal of renal calculi and ureteral calculi however, now a day is being used for biliary calculi. It has the advantages of simple operation, low cost, and higher safety. Recent studies show that the procedure time for ESWL is also shorter and the utilization rate of mechanical lithotripsy was effectively reduced with fewer complications. But It is difficult for ESWL to break the stones larger than 3cm into small pieces. So SpyGlass-guided laser lithotripsy is used. Spyglass has been used in clinics for more than ten years. Recently, a study reported difficult bile duct stones that were treated with SpyGlass-guided laser lithotripsy that shows promising results. Compared with laser lithotripsy under X-ray monitoring, there is no significant difference in stone removal rate and complication rate between the two methods. However, the effect of lithotripsy under Spyglass direct vision is better, which can break large stones into smaller pieces, thus making it easier to take stones. The investigators conducted the current study to compare the therapeutic outcome and complications between SpyGlass direct vision lithotripsy and ESWL procedures for the removal of large bile duct stones ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05186350
Study type	Interventional
Source	First People's Hospital of Hangzhou
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2021
Completion date	January 25, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03536247` - Papillary Balloon Dilation Versus Intraductal Lithotripsy	N/A
Recruiting	`NCT05035433` - Effect of the Sequence of Dilatation and Lithotripsy on the Treatment of Choledocholithiasis With ERCP	N/A
Not yet recruiting	`NCT06060002` - Role of Prophylactic Biliary Stent in Reducing the Recurrence of Choledocholithiasis	N/A
Recruiting	`NCT06041113` - Recurrent Extrahepatic Bile Duct Stones as a Late Complication of ERCP in Patients With Coexisting Intra- and Extrahepatic Bile Duct Stones
Completed	`NCT02461147` - Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
Recruiting	`NCT00416234` - Laparoendoscopic Rendez Vous Versus Standard Two Stage Approach for the Management of Cholelithiasis/Choledocholithiasis	N/A
Active, not recruiting	`NCT05592795` - Explore the Effects and Mechanisms of ERCP and EST on Biliary Microecology
Recruiting	`NCT05056506` - EPLBD With Limited EST vs. EPLBD for Choledocholithiasis	N/A
Completed	`NCT02515474` - Comparison of LCBDE vs ERCP + LC for Choledocholithiasis	N/A
Recruiting	`NCT05429203` - Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope	N/A
Completed	`NCT01824186` - Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy	N/A
Completed	`NCT02647593` - The Clinical Characteristics of the Patients With Choledocholithiasis Without Cholangitis
Not yet recruiting	`NCT06066372` - Application of Machine Learning Models to Reduce Need for Diagnostic EUS or MRCP in Patients With Intermediate Likelihood of Choledocholithiasis
Completed	`NCT04716166` - Incentive Spirometry and Upper Abdominal Laparoscopic Surgery	N/A
Completed	`NCT03074201` - Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP	N/A
Withdrawn	`NCT01475864` - Prospective Evaluation of the Covered Self-expandable Metal Stents (CSEMS) for Incomplete Biliary Stone Clearance	N/A
Recruiting	`NCT06265311` - IDUS in CBD Stone Recurrence High Risk Patients	N/A
Completed	`NCT02870686` - EUS Guided ERCP in Bile Duct Stone Removal	N/A
Recruiting	`NCT05611840` - RCT on Robotic vs. Endo-laparoscopic Approach for Difficult Choledocholithiasis	N/A
Recruiting	`NCT03102281` - Microbiomes in Patients of Recurrent Common Bile Duct Stones	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.